Vehicle

Drug identity checked against registry records

Also recorded as Placebo

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic DermatitisNCT05432596ACRSPhase 2Completed2023-10-26Actual
A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia CongenitaNCT05180708PVLAPhase 3Completed2023-06-30Actual
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCEDNCT05966493Glaukos CorporationPhase 2Recruiting2025-12Estimated
Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic DermatitisNCT04598269ACRSPhase 2Completed2021-04-08Actual
A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)NCT07355075Turn TherapeuticsPhase 2, Phase 3Recruiting2027-01-20Estimated
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton SyndromeNCT05521438Quoin PharmaceuticalsPhase 2, Phase 3Active not recruiting2025-12-30Actual
A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryNCT05147233OculisPhase 3Completed2023-06-22Actual
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)NCT06172257OculisPhase 3Completed2026-04-02Actual
NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular InjuriesNCT04081103Glaukos CorporationPhase 2Terminated2022-02-07Actual
Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the KneeNCT04120402EPRXPhase 2Completed2023-05-17Actual
Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary HyperhidrosisNCT02129660Journey Medical CorporationPhase 2Completed2015-01Actual
A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryNCT06128369OculisPhase 3Terminated2024-05-02Actual
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)NCT05066997OculisPhase 2, Phase 3Completed2026-04-10Actual
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)NCT07246590VRCAPhase 3Active not recruiting2026-11Estimated
Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)NCT07443202TARSPhase 2Enrolling by invitation2026-12-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.